2m 2m 2m 2m 2m 2m 2m
MINK THERAP (INKT)
NASDAQ
$12.54-$0.22 (-1.73%)
Price as of Jun 03, 2026 7:57 PM EDT- $60.8MMarket Cap
- 67.74%1-Year Change
- BiotechnologyIndustry
MINK THERAP (INKT)
$12.54-$0.22 (-1.73%)
INKT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.76 | ||
Change | -$0.42 (-3.39%) | ||
Open | $11.97 | ||
High | $12.84 | ||
Low | $11.63 | ||
Previous Close | $11.96 | ||
Volume | 37,666 | ||
30-Day Average Volume | 41,551 | ||
1-Week Change | 14.56% | ||
1-Month Change | 3.01% | ||
1-Year Change | 67.74% | ||
3-Year Change | -34.64% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 5.0M | ||
Total Assets | $10.4M | ||
Market Cap | $60.8M | ||
Enterprise Value | $56.3M | ||
Period: QTR TTM FY | |||
Revenue | $80,834.00 | ||
Net Income | -$2.7M | ||
Free Cash Flow | -$1.7M | ||
EBIT | -$2.7M | ||
EBITDA | -$2.7M | ||
Net Working Capital | $2.7M | ||
EPS | -$0.57 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | 696 | ||
P/B | -5 | ||
P/E | -21 | ||
PEG | 8 | ||
Price/Free Cash Flow | -35 | ||
Price/Operating Cash Flow | -35 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 01/28/2025 | ||
Earnings & Revenue